Pyoderma gangrenosum

• 1  Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004;43:790–800. Cross Ref link Pubmed link
• 2  Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 2012;132:2166–70. Cross Ref link Pubmed link
• 3  Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 2011;165:1244–50. Cross Ref link Pubmed link
• 4  Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000;79(1):37–46. Cross Ref link Pubmed link
• 5  Vidal D, Puig L, Gilaberte M, Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatol Treat 2004;15(3):146–152. Cross Ref link
• 6  Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol 2000;18(3):283–93. Cross Ref link Pubmed link
• 7  Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007;33:787–802, vi. Cross Ref link Pubmed link
• 8  Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985;55(217):173–86. Pubmed link
• 9  Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007;33(4):787–802, vi. Cross Ref link Pubmed link
• 10  Braun‐Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) – a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012;66:409–15. Cross Ref link Pubmed link
• 11  Manguso F, Sanges M, Staiano T, et al. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 2004;99(2):327–34. Cross Ref link Pubmed link
• 12  Wu XR, Mukewar S, Kiran RP, Remzi FH, Hammel J, Shen B. Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease. J Crohns Colitis 2013;7:e171–7. Cross Ref link Pubmed link
• 13  Crowson AN, Mihm MC Jr, Magro C, Crowson AN, Mihm MCJ, Magro C. Pyoderma gangrenosum: a review [review] [157 refs]. J Cutan Pathol 2003;30(2):97–107. Cross Ref link Pubmed link
• 14  Su WP, Schroeter AL, Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 1986;13(5):323–30. Cross Ref link Pubmed link
• 15  Seo JW, Son HH, Choi JH, Lee SK. A case of p‐ANCA‐positive propylthiouracil‐induced pyoderma gangrenosum. Ann Dermatol 2010;22(1):48–50. Cross Ref link Pubmed link
• 16  Grattan CE, McCann BG, Lockwood CM. Pyoderma gangrenosum, polyarthritis and lung cysts with novel antineutrophil cytoplasmic antibodies to azurocidin. Br J Dermatol 1998;139(2):352–3. Cross Ref link Pubmed link
• 17  Hoffman MD, Hoffman MD. Pyoderma gangrenosum associated with c‐ANCA (h‐lamp‐2). Int J Dermatol 2001;40(2):135–7. Cross Ref link Pubmed link
• 18  Magro CM, Kiani B, Li J, et al. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease. J Cutan Pathol 2007;34(7):526–34. Cross Ref link Pubmed link
• 19  Nerella P, Daniela A, Guido M, et al. Leukocyte chemotaxis and pyoderma gangrenosum. Int J Dermatol 1985;24(1):45–7. Cross Ref link Pubmed link
• 20  Oka M, Berking C, Nesbit M, et al. Interleukin‐8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 2000;80(4):595–604. Cross Ref link Pubmed link
• 21  Oka M, Oka M. Pyoderma gangrenosum and interleukin 8. Br J Dermatol 2007;157(6):1279–81. Cross Ref link Pubmed link
• 22  Marzano AV, Fanoni D, Antiga E, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol 2014;178:48–56. Cross Ref link Pubmed link
• 23  Ullman S, Halberg P, Howitz J. Deposits of complement and immunoglobulins in vessel walls in pyoderma gangrenosum. Acta Derm Venereol 1982;62(4):340–1. Pubmed link
• 24  Holt PJ, Davies MG, Saunders KC, Nuki G. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 1980;59(2):114–33. Cross Ref link Pubmed link
• 25  Prystowsky JH, Kahn SN, Lazarus GS, Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Review of 21 cases [review] [36 refs]. Arch Dermatol 1989;125(1):57–64. Cross Ref link Pubmed link
• 26  Callen JP, Callen JP. Acute febrile neutrophilic dermatosis (Sweet's syndrome) and the related conditions of “bowel bypass” syndrome and bullous pyoderma gangrenosum. Dermatol Clin 1985;3(1):153–63. Pubmed link
• 27  Bister V, Makitalo L, Jeskanen L, et al. Expression of MMP‐9, MMP‐10 and TNF‐alpha and lack of epithelial MMP‐1 and MMP‐26 characterize pyoderma gangrenosum. J Cutan Pathol 2007;34(12):889–98. Cross Ref link Pubmed link
• 28  Brooklyn TN, Williams AM, Dunnill MG, et al. T‐cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking. Br J Dermatol 2007;157(5):960–6. Cross Ref link Pubmed link
• 29  Mittal S, Milner BJ, Vickers MA, Mittal S, Milner BJ, Vickers MA. Pyoderma gangrenosum as a cause of splenomegaly and association with a T‐cell clone. Clin Lab Haematol 2005;27(6):402–4. Cross Ref link Pubmed link
• 30  Das KM, Squillante L, Chitayet D, et al. Simultaneous appearance of a unique common epitope in fetal colon, skin, and biliary epithelial cells. A possible link for extracolonic manifestations in ulcerative colitis. J Clin Gastroenterol 1992;15(4):311–16. Cross Ref link Pubmed link
• 31  Lazarus GS, Goldsmith LA, Rocklin RE, et al. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol 1972;105(1):46–51. Cross Ref link Pubmed link
• 32  Marzano AV, Ceccherini I, Gattorno M, et al. Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) 2014;93(27):e187. Cross Ref link Pubmed link
• 33  Marks DJ, Rahman FZ, Novelli M, et al. An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum. Gut 2006;55(11):1662–3. Cross Ref link Pubmed link
• 34  Tallon B, Corkill M. Peculiarities of PAPA syndrome. Rheumatology (Oxford) 2006;45(9):1140–3. Cross Ref link Pubmed link
• 35  Veillette A, Rhee I, Souza CM, et al. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders [review] [76 refs]. Immunol Rev 2009;228(1):312–24. Cross Ref link Pubmed link
• 36  Waite AL, Schaner P, Richards N, et al. Pyrin modulates the intracellular distribution of PSTPIP1. PLOS One 2009;4(7):e6147. Cross Ref link Pubmed link
• 37  Shoham NG, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Nat Acad Sci U S A 2003;100(23):13501–6. Cross Ref link
• 38  Khandpur S, Mehta S, Reddy BS, Khandpur S, Mehta S, Reddy BS. Pyoderma gangrenosum in two siblings: a familial predisposition. Pediatr Dermatol 2001;18(4):308–12. Cross Ref link Pubmed link
• 39  Alberts JH, Sams HH, Miller JL, et al. Familial ulcerative pyoderma gangrenosum: a report of 2 kindred. Cutis 2002;69(6):427–30. Pubmed link
• 40  Farhi D, Wallach D, Avril MF. [Pyoderma gangrenosum is 100 years old. From Louis Brocq to biotherapies.] Rev Prat 2008;58(4):457–61. Pubmed link
• 41  Brunsting LA, Eckerman W, O'Leary PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930;22:655–80. Cross Ref link
• 42  Greenstein AJ, Janowitz HD, Sachar DB. The extra‐intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55(5):401–12. Cross Ref link Pubmed link
• 43  Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007;33(4):787–802, vi. Cross Ref link Pubmed link
• 44  Callen JP, Callen JP. Pyoderma gangrenosum [review] [39 refs]. Lancet 1998;351(9102):581–5. Cross Ref link Pubmed link
• 45  Powell FC, Schroeter AL, Su WP, et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985;55(217):173–86. Pubmed link
• 46  Wollina U. Pyoderma gangrenosum – a review. Orphanet J Rare Dis 2007;2:19. Cross Ref link Pubmed link
• 47  Leger M, Newlove T, Chu J, Meehan S, Stein J. Pustular pyoderma gangrenosum. Dermatol Online J 2011;17(10):17. Pubmed link
• 48  Chia MW, Teo L, Tay YK, Poh WT. Pustular pyoderma gangrenosum: an uncommon variant which is easily misdiagnosed. Dermatol Online J 2008;14(2):21. Pubmed link
• 49  Shankar S, Sterling JC, Rytina E. Pustular pyoderma gangrenosum. Clin Exp Dermatol 2003;28(6):600–3. Cross Ref link Pubmed link
• 50  Ahmadi S, Powell FC. Pyoderma gangrenosum: uncommon presentations. Clin Dermatol 2005;23(6):612–20. Cross Ref link Pubmed link
• 51  Brouard MC, Chavaz P, Borradori L. Acute pustulosis of the legs in diverticulitis with sigmoid stenosis: an overlap between bowel‐associated dermatosis–arthritis syndrome and pustular pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2004;18(1):89–92. Cross Ref link Pubmed link
• 52  Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 1972;106(6):901–5. Cross Ref link Pubmed link
• 53  Hay CR, Messenger AG, Cotton DW, Bleehen SS, Winfield DA. Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J Clin Pathol 1987;40(4):387–92. Cross Ref link Pubmed link
• 54  Cramers M. Bullous pyoderma gangrenosum in association with myeloid leukaemia. Acta Derm Venereol 1976;56(4):311–12. Pubmed link
• 55  Fox LP, Geyer AS, Husain S, Grossman ME. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia. Leuk Lymphoma 2006;47(1):147–50. Cross Ref link Pubmed link
• 56  Sheps M, Shapero H, Ramsay C. Bullous pyoderma gangrenosum and acute leukemia. Arch Dermatol 1978;114(12):1842–3. Cross Ref link Pubmed link
• 57  Winkelmann RK, Wilson‐Jones E, Gibson LE, Quimby SR. Histopathologic features of superficial granulomatous pyoderma. J Dermatol 1989;16(2):127–32. Cross Ref link Pubmed link
• 58  Wilson‐Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988;18(3):511–21. Cross Ref link Pubmed link
• 59  Langan SM, Powell FC. Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature. Int J Dermatol 2005;44(8):623–9. Cross Ref link Pubmed link
• 60  Vignon‐Pennamen MD, Zelinsky‐Gurung A, Janssen F, Frija J, Wallach D. Pyoderma gangrenosum with pulmonary involvement. Arch Dermatol 1989;125(9):1239–42. Cross Ref link Pubmed link
• 61  Fukuhara K, Urano Y, Kimura S, Hori K, Arase S. Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone. Br J Dermatol 1998;139(3):556–8. Cross Ref link Pubmed link
• 62  Mlika RB, Riahi I, Fenniche S, et al. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol 2002;41(2):65–8. Cross Ref link Pubmed link
• 63  Dagan O, Barak Y, Metzker A. Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol 1995;12(1):39–42. Cross Ref link Pubmed link
• 64  Williamson D, Sibbald RG. Chronic recurrent multifocal osteomyelitis: a rare association with pyoderma gangrenosum in adults. Br J Dermatol 2002;147(3):611–13. Cross Ref link Pubmed link
• 65  Matsumura Y, Nishiwaki F, Morita N, Kore‐Eda S, Miyachi Y. Pyoderma gangrenosum in a patient with myelodysplastic syndrome followed by possible extracutaneous manifestations in the gallbladder, liver, bone and lung. J Dermatol 2011;38(11):1102–5. Cross Ref link Pubmed link
• 66  Rodot S, Lacour JP, Van EL, Cognard C, Castanet J, Ortonne JP. [Extracutaneous manifestations of neutrophilic dermatosis.] Ann Dermatol Venereol 1996;123(2):129–34. Pubmed link
• 67  Goldshmid O, Dovorish Z, Zehavi T, Eisen A, Bar‐Dayan Y, Amital H. Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn's disease: case report and review of the literature. Rheumatol Int 2011;31(4):525–7. Cross Ref link Pubmed link
• 68  Weenig RH, Davis MD, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum [review] [54 refs]. N Engl J Med 2002;347(18):1412–18. Cross Ref link Pubmed link
• 69  Weenig RH, Davis MD, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum [review] [54 refs]. N Engl J Med 2002;347(18):1412–18. Cross Ref link Pubmed link
• 70  Byrd DR, El‐Azhary RA, Gibson LE, et al. Sporotrichosis masquerading as pyoderma gangrenosum: case report and review of 19 cases of sporotrichosis. J Eur Acad Dermatol Venereol 2001;15(6):581–4. Cross Ref link Pubmed link
• 71  Hsu CK, Hsu MM, Lee JY, Hsu CK, Hsu MM‐L, Lee JY‐Y. Fusariosis occurring in an ulcerated cutaneous CD8+ T cell lymphoma tumor. Eur J Dermatol 2006;16(3):297–301. Pubmed link
• 72  Hunter AJ, Bryant RE, Hunter AJ, Bryant RE. Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole. J Infect 2002;44(3):203–4. Cross Ref link Pubmed link
• 73  Laochumroonvorapong P, DiCostanzo DP, Wu H, et al. Disseminated histoplasmosis presenting as pyoderma gangrenosum‐like lesions in a patient with acquired immunodeficiency syndrome. Int J Dermatol 2001;40(8):518–21. Cross Ref link Pubmed link
• 74  Mason AR, Cortes GY, Cook J, et al. Cutaneous blastomycosis: a diagnostic challenge. Int J Dermatol 2008;47(8):824–30. Cross Ref link Pubmed link
• 75  Smith VM, Lyon CC. Nicorandil: do the dermatological and gastrointestinal risks outweigh the benefits? Br J Dermatol 2012;167(5):1048–52. Cross Ref link Pubmed link
• 76  Craig FF, Thomas KS, Mitchell EJ, et al. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial. Trials 2012;13:51. Cross Ref link Pubmed link
• 77  Foss CE, Clark AR, Inabinet R, Camacho F, Jorizzo JL. An open‐label pilot study of alefacept for the treatment of pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2008;22(8):943–9. Cross Ref link Pubmed link
• 78  Al GP, Korber A, Klode J, Dissemond J. Investigation of new co‐factors in 49 patients with pyoderma gangrenosum. J Dtsch Dermatol Ges 2012;10(4):251–7. Pubmed link
• 79  Hasselmann DO, Bens G, Tilgen W, Reichrath J. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges 2007;5(7):560–4. Cross Ref link Pubmed link
• 80  Pereira N, Brites MM, Goncalo M, Tellechea O, Figueiredo A. Pyoderma gangrenosum – a review of 24 cases observed over 10 years. Int J Dermatol 2013;52(8):938–45. Cross Ref link Pubmed link
• 81  Mlika RB, Riahi I, Fenniche S, et al. Pyoderma gangrenosum: a report of 21 cases. Int J Dermatol 2002;41(2):65–8. Cross Ref link Pubmed link
• 82  Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence‐based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005;53(2):273–83. Cross Ref link Pubmed link
• 83  Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 2010;62(4):646–54. Cross Ref link Pubmed link
• 84  Marzano AV, Trevisan V, Lazzari R, Crosti C. Pyoderma gangrenosum: study of 21 patients and proposal of a ‘clinicotherapeutic’ classification. J Dermatol Treat 2011;22(5):254–60. Cross Ref link
• 85  Wenzel J, Gerdsen R, Phillipp‐Dormston W, Bieber T, Uerlich M. Topical treatment of pyoderma gangraenosum. Dermatology 2002;205(3):221–3. Cross Ref link Pubmed link
• 86  Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatol Treat 2001;12(1):13–17. Cross Ref link
• 87  Rice SA, Woo PN, El‐Omar E, Keenan RA, Ormerod AD. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. BMC Res Notes 2013;6:19. Cross Ref link Pubmed link
• 88  Ormerod AD, Thomas KS, Craig FE, et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 2015 Jun 12;350:h2958, doi: 10.1136/bmj.h2958. Cross Ref link Pubmed link
• 89  Agarwal A, Andrews JM. Systematic review: IBD‐associated pyoderma gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther 2013;38:563–72. Cross Ref link Pubmed link
• 90  Arguelles‐Arias F, Castro‐Laria L, Lobaton T, et al. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci 2013;58(10):2949–54. Cross Ref link Pubmed link
• 91  Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006;55:505–9. Cross Ref link Pubmed link
• 92  Kaufman I, Caspi D, Yeshurun D, et al. The effect of infliximab on extraintestinal manifestations of Crohn's disease. Rheumatol Int 2005;25(6):406–10. Cross Ref link Pubmed link
• 93  Ljung T, Staun M, Grove O, et al. Pyoderma gangrenosum associated with Crohn disease: effect of TNF‐alpha blockade with infliximab. Scand J Gastroenterol 2002;37(9):1108–10. Cross Ref link Pubmed link
• 94  Mimouni D, Anhalt GJ, Kouba DJ, et al. Infliximab for peristomal pyoderma gangrenosum. Br J Dermatol 2003;148(4):813–16. Cross Ref link Pubmed link
• 95  Regueiro M, Valentine J, Plevy S, et al. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003;98(8):1821–6. Cross Ref link Pubmed link
• 96  Sapienza MS, Cohen S, Dimarino AJ, Sapienza MS, Cohen S, Dimarino AJ. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease. Dig Dis Sci 2004;49(9):1454–7. Cross Ref link Pubmed link
• 97  Fonder MA, Cummins DL, Ehst BD, Anhalt GJ, Meyerle JH. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 2006;5:e8. Pubmed link
• 98  Hubbard VG, Friedmann AC, Goldsmith P. Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 2005;152(5):1059–61. Cross Ref link Pubmed link
• 99  Zold E, Nagy A, Devenyi K, Zeher M, Barta Z. Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone. World J Gastroenterol 2009;15(18):2293–5. Cross Ref link Pubmed link
• 100  Mooij JE, van R, Mekkes JR. Six patients with pyoderma gangrenosum successfully treated with infliximab. Int J Dermatol 2013;52(11):1418–20. Cross Ref link Pubmed link
• 101  Jacob SE, Weisman RS, Kerdel FA. Pyoderma gangrenosum – rebel without a cure? Int J Dermatol 2008;47(2):192–4. Cross Ref link Pubmed link
• 102  Charles CA, Leon A, Banta MR, Kirsner RS. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series. Int J Dermatol 2007;46(10):1095–9. Cross Ref link Pubmed link
• 103  Goldenberg G, Jorizzo JL. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis. J Dermatol Treat 2005;16(5–6):347–9. Cross Ref link
• 104  McGowan JW, Johnson CA, Lynn A, McGowan JW, Johnson CA, Lynn A. Treatment of pyoderma gangrenosum with etanercept. J Drugs Dermatol 2004;3(4):441–4. Pubmed link
• 105  Rogge FJ, Pacifico M, Kang N, Rogge FJ, Pacifico M, Kang N. Treatment of pyoderma gangrenosum with the anti‐TNFalpha drug – Etanercept. J Plast Reconstr Aesth Surg 2008;61(4):431–3. Cross Ref link
• 106  Kowalzick L, Bertolini J, Baumann C, Walther B, Truhm B, Eickenscheidt L. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis. J Dtsch Dermatol Ges 2013;11(5):447–9. Pubmed link
• 107  Kikuchi N, Hiraiwa T, Ohashi T, et al. Pyoderma gangrenosum possibly triggered by adalimumab. Eur J Dermatol 2012;22(6):804–5. Pubmed link
• 108  Fahmy M, Ramamoorthy S, Hata T, Sandborn WJ. Ustekinumab for peristomal pyoderma gangrenosum. Am J Gastroenterol 2012;107(5):794–5. Cross Ref link Pubmed link
• 109  Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin‐1 receptor antagonist anakinra. Br J Dermatol 2009;161(5):1199–201. Cross Ref link Pubmed link
• 110  Geusau A, Mothes‐Luksch N, Nahavandi H, et al. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA‐like syndrome responding to canakinumab treatment. JAMA Dermatol 2013;149(2):209–15. Cross Ref link Pubmed link
• 111  Braun‐Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) – a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012;66(3):409–15. Cross Ref link Pubmed link
• 112  Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti‐tumor necrosis factor alpha therapy. J Clin Rheumatol 2012;18(8):413–15. Cross Ref link Pubmed link
• 113  Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 2007;157(6):1235–9. Cross Ref link Pubmed link
• 114  Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 2002;3(3):149–58. Cross Ref link Pubmed link
• 115  Rados J, Pastar Z, Rudman F, Milavec‐Puretic V, Lipozencic J, Dobric I. Pyoderma chronica vegetans treated with mesh skin grafting. Acta Dermatovenerol Croat 2011;19(3):180–2. Pubmed link

Sweet syndrome

• 116  Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964 Aug–Sep;76:349–56. Cross Ref link Pubmed link
• 117  Cohen PR, Kurzrock R. Sweet's syndrome and cancer. Clin Dermatol 1993 Jan–Mar;11(1):149–57. Cross Ref link Pubmed link
• 118  Bourke JF, Keohane S, Long CC, et al. Sweet's syndrome and malignancy in the U.K. Br J Dermatol 1997 Oct;137(4):609–13. Cross Ref link Pubmed link
• 119  Boatman BW, Taylor RC, Klein LE, Cohen BA. Sweet's syndrome in children. South Med J 1994 Feb;87(2):193–6. Cross Ref link Pubmed link
• 120  Cohen PR, Talpaz M, Kurzrock R. Malignancy‐associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988 Dec;6(12):1887–97. Pubmed link
• 121  Cohen PR. Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34. Cross Ref link Pubmed link
• 122  Catalan‐Serra I, Martin‐Moraleda L, Navarro‐Lopez L, et al. Crohn's disease and Sweet's syndrome: an uncommon association. Rev Esp Enferm Dig 2010 May;102(5):331–7. Pubmed link
• 123  Rahier JF, Lion L, Dewit O, Lambert M. Regression of Sweet's syndrome associated with Crohn's disease after anti‐Tumour Necrosis Factor therapy. Acta Gastroenterol Belg 2005 Jul–Sep;68(3):376–9. Pubmed link
• 124  Smith SE, Gillon JT, Ferguson SB. Targetoid palmoplantar Sweet syndrome as presenting sign of severe Crohn's disease. J Am Acad Dermatol 2013 Oct;69(4):e199–200. Cross Ref link Pubmed link
• 125  Gillott TJ, Whallett AJ, Struthers GR, Ilchyshyn A. Concurrent Sweet's syndrome (acute febrile neutrophilic dermatosis), erythema nodosum and sarcoidosis. Clin Exp Dermatol 1997 Jan;22(1):54–6. Cross Ref link Pubmed link
• 126  Wilkinson SM, Heagerty AH, English JS. Acute febrile neutrophilic dermatosis in association with erythema nodosum and sarcoidosis. Clin Exp Dermatol 1993 Jan;18(1):47–9. Cross Ref link Pubmed link
• 127  Pouchot J, Bourgeois‐Droin C, et al. Sweet's syndrome and mediastinal lymphadenopathy due to sarcoidosis: three cases of a new association. Arch Dermatol 1993 Aug;129(8):1062–4. Cross Ref link Pubmed link
• 128  Wilson DM, John GR, Callen JP. Peripheral ulcerative keratitis – an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol 1999 Feb;40(2 Pt 2):331–4. Cross Ref link Pubmed link
• 129  Lee MS, Barnetson RS. Sweet's syndrome associated with Behcet's disease. Australas J Dermatol 1996 May;37(2):99–101. Cross Ref link Pubmed link
• 130  Waltz KM, Long D, Marks JG Jr, Billingsley EM. Sweet's syndrome and erythema nodosum: the simultaneous occurrence of 2 reactive dermatoses. Arch Dermatol 1999 Jan;135(1):62–6. Cross Ref link Pubmed link
• 131  Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R. Sweet syndrome in patients with solid tumors. Cancer 1993 Nov 1;72(9):2723–31. Cross Ref link Pubmed link
• 132  Cohen PR, Kurzrock R. Chronic myelogenous leukemia and Sweet syndrome. Am J Hematol 1989 Oct;32(2):134–7. Cross Ref link Pubmed link
• 133  Tazi I, Nafil H, Mahmal L. Immunoglobulin a multiple myeloma associated with sweet syndrome. J Cancer Res Ther 2012 Oct–Dec;8(4):652–3. Cross Ref link Pubmed link
• 134  Bayer‐Garner IB, Cottler‐Fox M, Smoller BR. Sweet syndrome in multiple myeloma: a series of six cases. J Cutan Pathol 2003 Apr;30(4):261–4. Cross Ref link Pubmed link
• 135  Culp L, Crowder S, Hatch S. A rare association of Sweet's syndrome with cervical cancer. Gynecol Oncol 2004 Nov;95(2):396–9. Cross Ref link Pubmed link
• 136  Hussein K, Nanda A, Al‐Sabah H, Alsaleh QA. Sweet's syndrome (acute febrile neutrophilic dermatosis) associated with adenocarcinoma of prostate and transitional cell carcinoma of urinary bladder. J Eur Acad Dermatol Venereol 2005 Sep;19(5):597–9. Cross Ref link Pubmed link
• 137  Raza S, Kirkland RS, Patel AA, Shortridge JR, Freter C. Insight into Sweet's syndrome and associated‐malignancy: a review of the current literature. Int J Oncol 2013 May;42(5):1516–22. Pubmed link
• 138  Parsapour K, Reep MD, Gohar K, Shah V, Church A, Shwayder TA. Familial Sweet's syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol 2003 Jul;49(1):132–8. Cross Ref link Pubmed link
• 139  Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol 2010 Aug;31(8):318–24. Cross Ref link Pubmed link
• 140  Abtin A, Jain R, Mitchell AJ, et al. Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat Immunol 2014 Jan;15(1):45–53. Cross Ref link Pubmed link
• 141  Bourke JF, Jones JL, Fletcher A, Graham‐Brown RA. An immunohistochemical study of the dermal infiltrate and epidermal staining for interleukin 1 in 12 cases of Sweet's syndrome. Br J Dermatol 1996 Apr;134(4):705–9. Cross Ref link Pubmed link
• 142  Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer‐related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009 Jul;30(7):1073–81. Cross Ref link Pubmed link
• 143  Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony‐stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol 2004 May;140(5):570–4. Cross Ref link Pubmed link
• 144  Kumar G, Bernstein JM, Waibel JS, Baumann MA. Sweet's syndrome associated with sargramostim (granulocyte–macrophage colony stimulating factor) treatment. Am J Hematol 2004 Jul;76(3):283–5. Cross Ref link Pubmed link
• 145  Shinojima Y, Toma Y, Terui T. Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony–stimulating factor. Br J Dermatol 2006 Nov;155(5):1103–4. Cross Ref link Pubmed link
• 146  Chan MP, Duncan LM, Nazarian RM. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol 2013 Jun;68(6):1006–15. Cross Ref link Pubmed link
• 147  Dong A, Wang Y, Gao L, Zuo C. 18F‐FDG PET/CT findings in a patient with Sweet syndrome associated with myelodysplastic syndrome. Clin Nucl Med 2013 Dec;38(12):e454–7. Cross Ref link Pubmed link
• 148  Martinelli S, Rigolin GM, Leo G, et al. Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome. Int J Hematol 2014 Feb 20. Pubmed link
• 149  Ono S, Otsuka A, Kabashima K, Miyachi Y, Tachibana T. Sweet's syndrome presenting as drastically spreading generalized erythema with subcorneal pustulosis in myelodysplastic syndrome. J Dermatol 2013 Dec;40(12):1072–3. Cross Ref link Pubmed link
• 150  Pinal‐Fernandez I, Ferrer Fabrega B, Ramentol Sintas M, Solans Laque R. Histiocytoid Sweet syndrome and cutaneous polyarteritis nodosa secondary to myelodysplastic syndrome. Int J Rheum Dis 2013 Dec;16(6):777–9. Cross Ref link Pubmed link
• 151  Pai S, Rytina E, Sterling J, Karas JA, Aliyu SH. Campylobacter gastroenteritis associated with Sweet's syndrome. J Med Microbiol 2012 Oct;61(Pt 10):1473–5. Cross Ref link Pubmed link
• 152  Kohanbash G, McKaveney K, Sakaki M, et al. GM–CSF promotes the immunosuppressive activity of glioma‐infiltrating myeloid cells through interleukin‐4 receptor‐alpha. Cancer Res 2013 Nov 1;73(21):6413–23. Cross Ref link Pubmed link
• 153  Wang Y, Han G, Wang K, et al. Tumor‐derived GM‐CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF. Cancer Res 2014 Feb 1;74(3):716–26. Cross Ref link Pubmed link
• 154  Takahashi T, Hato F, Yamane T, et al. Activation of human neutrophil by cytokine‐activated endothelial cells. Circ Res 2001 Mar 2;88(4):422–9. Cross Ref link Pubmed link
• 155  Takahashi T, Nishizawa Y, Hato F, et al. Neutrophil‐activating activity and platelet‐activating factor synthesis in cytokine‐stimulated endothelial cells: reduced activity in growth‐arrested cells. Microvasc Res 2007 Jan;73(1):29–34. Cross Ref link Pubmed link
• 156  Ratzinger G, Burgdorf W, Zelger BG, Zelger B. Acute febrile neutrophilic dermatosis: a histopathologic study of 31 cases with review of literature. Am J Dermatopathol 2007 Apr;29(2):125–33. Cross Ref link Pubmed link
• 157  Malone JC, Slone SP, Wills‐Frank LA, et al. Vascular inflammation (vasculitis) in sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol 2002 Mar;138(3):345–9. Cross Ref link Pubmed link
• 158  Escallier F, Gaudard S, Courtois JM, Dalac S, Collet E, Lambert D. [Sweet's syndrome and Yersinia enterocolitica infection.] Ann Dermatol Venereol 1990;117(11):858–60. Pubmed link
• 159  Karmakar PS, Sherpa PL, Ray AN, et al. Sweet's syndrome: a very rare association with pulmonary tuberculosis. J Infect Dev Ctries 2013 May;7(5):417–20. Cross Ref link Pubmed link
• 160  Freitas DF, Valle AC, Cuzzi T, Brandao LG, Zancope‐Oliveira RM, Galhardo MC. Sweet syndrome associated with sporotrichosis. Br J Dermatol 2012 Jan;166(1):212–13. Cross Ref link Pubmed link
• 161  Shimizu T, Yoshida I, Eguchi H, Takahashi K, Inada H, Kato H. Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony‐stimulating factor. J Pediatr Hematol Oncol 1996 Aug;18(3):282–4. Cross Ref link Pubmed link
• 162  Garty BZ, Levy I, Nitzan M, Barak Y. Sweet syndrome associated with G‐CSF treatment in a child with glycogen storage disease type Ib. Pediatrics 1996 Mar;97(3):401–3. Pubmed link
• 163  Walker DC, Cohen PR. Trimethoprim‐sulfamethoxazole‐associated acute febrile neutrophilic dermatosis: case report and review of drug‐induced Sweet's syndrome. J Am Acad Dermatol 1996 May;34(5 Pt 2):918–23. Cross Ref link Pubmed link
• 164  Gottlieb CC, Mishra A, Belliveau D, Green P, Heathcote JG. Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature. Surv Ophthalmol 2008 May–Jun;53(3):219–26. Cross Ref link Pubmed link
• 165  Druschky A, von den Driesch P, Anders M, Claus D, Neundorfer B. Sweet's syndrome (acute febrile neutrophilic dermatosis) affecting the central nervous system. J Neurol 1996 Jul;243(7):556–7. Cross Ref link Pubmed link
• 166  Chiba S. Sweet's syndrome with neurologic signs and psychiatric symptoms. Arch Neurol 1983 Dec;40(13):829. Cross Ref link Pubmed link
• 167  Thurnheer R, Stammberger U, Hailemariam S, Russi EW. Bronchial manifestation of acute febrile neutrophilic dermatosis (Sweet's syndrome). Eur Respir J 1998 Apr;11(4):978–80. Cross Ref link Pubmed link
• 168  Takahama H, Kanbe T. Neutrophilic dermatosis of the dorsal hands: a case showing HLA B54, the marker of Sweet's syndrome. Int J Dermatol 2010 Sep;49(9):1079–80. Cross Ref link Pubmed link
• 169  Walling HW, Snipes CJ, Gerami P, Piette WW. The relationship between neutrophilic dermatosis of the dorsal hands and sweet syndrome: report of 9 cases and comparison to atypical pyoderma gangrenosum. Arch Dermatol 2006 Jan;142(1):57–63. Cross Ref link Pubmed link
• 170  Kung EF, Arora A, Petronic‐Rosic V, Tsoukas MM. Clinicopathologic challenge. Neutrophilic dermatosis of the dorsal hands – a variant of localized Sweet's syndrome. Int J Dermatol 2009 Jun;48(6):555–7. Cross Ref link Pubmed link
• 171  Cohen PR. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: an oxymoron or an epiphenomenon? Arch Dermatol 2002 Mar;138(3):400–3. Cross Ref link Pubmed link
• 172  Weenig RH, Bruce AJ, McEvoy MT, Gibson LE, Davis MD. Neutrophilic dermatosis of the hands: four new cases and review of the literature. Int J Dermatol 2004 Feb;43(2):95–102. Cross Ref link Pubmed link
• 173  Suzuki Y, Kuroda K, Kojima T, Fujita M, Iseki T, Shinkai H. Unusual cutaneous manifestations of myelodysplastic syndrome. Br J Dermatol 1995 Sep;133(3):483–6. Cross Ref link Pubmed link
• 174  Requena L, Kutzner H, Palmedo G, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 2005 Jul;141(7):834–42. Cross Ref link Pubmed link
• 175  Su WP, Liu HN. Diagnostic criteria for Sweet's syndrome. Cutis 1986 Mar;37(3):167–74. Pubmed link
• 176  Smith RA, Manassaram‐Baptiste D, Brooks D, et al. Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2014 Jan;64(1):30–51. Cross Ref link Pubmed link
• 177  Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 2002;3(2):117–31. Cross Ref link Pubmed link
• 178  Aram H. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone. Arch Dermatol 1984 Feb;120(2):245–7. Cross Ref link Pubmed link
• 179  Horio T, Imamura S, Danno K, Furukawa F, Ofuji S. Treatment of acute febrile neutrophilic dermatosis (Sweet's Syndrome) with potassium iodide. Dermatologica 1980;160(5):341–7. Cross Ref link Pubmed link
• 180  Suehisa S, Tagami H. Treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome) with colchicine. Br J Dermatol 1981 Oct;105(4):483. Cross Ref link Pubmed link
• 181  Suehisa S, Tagami H, Inoue F, Matsumoto K, Yoshikuni K. Colchicine in the treatment of acute febrile neutrophilic dermatosis (Sweet's syndrome). Br J Dermatol 1983 Jan;108(1):99–101. Cross Ref link Pubmed link
• 182  Jeanfils S, Joly P, Young P, Le Corvaisier‐Pieto C, Thomine E, Lauret P. Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):436–9. Cross Ref link Pubmed link
• 183  von den Driesch P, Steffan C, Zobe A, Hornstein OP. Sweet's syndrome – therapy with cyclosporin. Clin Exp Dermatol 1994 May;19(3):274–7. Cross Ref link Pubmed link
• 184  von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994 Oct;31(4):535–56; quiz 57–60. Cross Ref link Pubmed link
• 185  Haliasos E, Soder B, Rubenstein DS, Henderson W, Morrell DS. Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulin. Pediatr Dermatol 2005 Nov–Dec;22(6):530–5. Cross Ref link Pubmed link

Bowel‐associated dermatitis–arthritis syndrome

• 186  Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol 1980;2:473–87. Cross Ref link Pubmed link
• 187  Shagrin JW, Frame B, Duncan H. Polyarthritis in obese patients with intestinal bypass. Ann Intern Med 1971;75:377–80. Cross Ref link Pubmed link
• 188  Drenick EJ, Ament ME, Finegold SM, Passaro E Jr. Bypass enteropathy: an inflammatory process in the excluded segment with systemic complications. Am J Clin Nutr 1977;30:76–89. Pubmed link
• 189  Jorizzo JL, Apisarnthanarax P, Subrt P, et al. Bowel‐bypass syndrome without bowel bypass. Bowel‐associated dermatosis‐arthritis syndrome. Arch Intern Med 1983;143:457–61. Cross Ref link Pubmed link
• 190  Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology 2012;225:215–19. Cross Ref link Pubmed link
• 191  Jorizzo JL, Schmalstieg FC, Dinehart SM, et al. Bowel‐associated dermatosis‐arthritis syndrome. Immune complex‐mediated vessel damage and increased neutrophil migration. Arch Intern Med 1984;144:738–40. Cross Ref link Pubmed link
• 192  Gamble CN, Kimchi A, Depner TA, Christensen D. Immune complex glomerulonephritis and dermal vasculitis following intestinal bypass for morbid obesity. Am J Clin Pathol 1982;77:347–52. Cross Ref link Pubmed link
• 193  Dicken CH. Bowel‐associated dermatosis‐arthritis syndrome: bowel bypass syndrome without bowel bypass. Mayo Clin Proc 1984;59:43–6. Cross Ref link Pubmed link
• 194  Cox NH, Palmer JG. Bowel‐associated dermatitis‐arthritis syndrome associated with ileo‐anal pouch anastomosis, and treatment with mycophenolate mofetil. Br J Dermatol 2003;149:1296–7. Cross Ref link Pubmed link
• 195  Slater GH, Kerlin P, Georghiou PR, Fielding GA. Bowel‐associated dermatosis‐arthritis syndrome after biliopancreatic diversion. Obes Surg 2004;14:133–5. Cross Ref link Pubmed link
• 196  Brouard MC, Chavaz P, Borradori L. Acute pustulosis of the legs in diverticulitis with sigmoid stenosis: an overlap between bowel‐associated dermatosis‐arthritis syndrome and pustular pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2004;18:89–92. Cross Ref link Pubmed link
• 197  Fairris GM, Ashworth J, Cotterill JA. A dermatosis associated with bacterial overgrowth in jejunal diverticula. Br J Dermatol 1985;112:709–13. Cross Ref link Pubmed link
• 198  Prpic‐Massari L, Kastelan M, Brajac I, Cabrijan L, Zamolo G, Massari D. Bowel‐associated dermatosis‐arthritis syndrome in a patient with appendicitis. Med Sci Monit 2007;13:CS97–100. Pubmed link
• 199  Tucker SC, Chalmers RJ, Andrew SM, Odom NJ. Pustular vasculitis secondary to achalasia of the cardia. Br J Dermatol 2000;142:373–4. Cross Ref link Pubmed link
• 200  Guerre‐Schmidt AR, Pelletier F, Carbonnel F, Humbert P, Aubin F. [Dermatosis‐arthritis syndrome associated with Crohn's disease in a teenager.] Rev Med Interne 2006;27:874–7. Cross Ref link Pubmed link
• 201  Kawakami A, Saga K, Hida T, Jimbow K, Takahashi H. Fulminant bowel‐associated dermatosis‐arthritis syndrome that clinically showed necrotizing fasciitis‐like severe skin and systemic manifestations. J Eur Acad Dermatol Venereol 2006;20:751–3. Cross Ref link Pubmed link
• 202  Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel‐associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol 2011;52:e5–e7. Cross Ref link Pubmed link

Subcorneal pustular dermatosis

• 203  Kasha EE Jr, Epinette WW. Subcorneal pustular dermatosis (Sneddon‐Wilkinson disease) in association with a monoclonal IgA gammopathy: a report and review of the literature. J Am Acad Dermatol 1988;19(5 Pt 1):854–8. Cross Ref link Pubmed link
• 204  Delaporte E, Colombel JF, Nguyen‐Mailfer C, Piette F, Cortot A, Bergoend H. Subcorneal pustular dermatosis in a patient with Crohn's disease. Acta Derm Venereol 1992;72(4):301–2. Pubmed link
• 205  Venning VA, Ryan TJ. Subcorneal pustular dermatosis followed by pyoderma gangrenosum. Br J Dermatol 1986;115(1):117–18. Cross Ref link Pubmed link
• 206  Roger H, Thevenet JP, Souteyrand P, Sauvezie B. Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment. Ann Rheum Dis 1990;49(3):190–1. Cross Ref link Pubmed link
• 207  Lautenschlager S, Itin PH, Hirsbrunner P, Buchner SA. Subcorneal pustular dermatosis at the injection site of recombinant human granulocyte‐macrophage colony‐stimulating factor in a patient with IgA myeloma. J Am Acad Dermatol 1994;30(5 Pt 1):787–9. Cross Ref link Pubmed link
• 208  Grob JJ, Mege JL, Capo C, et al. Role of tumor necrosis factor‐alpha in Sneddon‐Wilkinson subcorneal pustular dermatosis. A model of neutrophil priming in vivo. J Am Acad Dermatol 1991;25(5 Pt 2):944–7. Cross Ref link Pubmed link
• 209  Iwatsuki K, Imaizumi S, Takagi M, Takigawa M, Tagami H. Intercellular IgA deposition in patients with clinical features of subcorneal pustular dermatosis. Br J Dermatol 1988;119(4):545–7. Cross Ref link Pubmed link
• 210  Lutz ME, Daoud MS, McEvoy MT, Gibson LE. Subcorneal pustular dermatosis: a clinical study of ten patients. Cutis 1998;61:203–8. Pubmed link
• 211  Ishii N, Ishida‐Yamamoto A, Hashimoto T. Immunolocalization of target autoantigens in IgA pemphigus. Clin Exp Dermatol 2004;29(1):62–6. Cross Ref link Pubmed link
• 212  Harman KE, Holmes G, Bhogal BS, McFadden J, Black MM. Intercellular IgA dermatosis (IgA pemphigus) – two cases illustrating the clinical heterogeneity of this disorder. Clin Exp Dermatol 1999;24(6):464–6. Cross Ref link Pubmed link
• 213  Kopp T, Sitaru C, Pieczkowski F, et al. IgA pemphigus – occurrence of anti‐desmocollin 1 and anti‐desmoglein 1 antibody reactivity in an individual patient. J Dtsch Dermatol Ges 2006;4(12):1045–50. Cross Ref link Pubmed link
• 214  Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol 1956;68:385–94. Cross Ref link Pubmed link
• 215  Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol 1979;100:61–8. Cross Ref link Pubmed link
• 216  Sneddon IB. Subcorneal pustular dermatosis. Int J Dermatol 1977;16(8):640–4. Cross Ref link Pubmed link
• 217  Hashimoto T, Inamoto N, Nakamura K, Nishikawa T. Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis. Arch Dermatol 1987;123(8):1062–5. Cross Ref link Pubmed link
• 218  Takata M, Inaoki M, Shodo M, Hirone T, Kaya H. Subcorneal pustular dermatosis associated with IgA myeloma and intraepidermal IgA deposits. Dermatology 1994;189 Suppl. 1:111–14. Cross Ref link Pubmed link
• 219  Todd DJ, Bingham EA, Walsh M, Burrows D. Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA. Br J Dermatol 1991;125(4):387–9. Cross Ref link Pubmed link
• 220  Wolff K. Subcorneal pustular dermatosis is not pustular psoriasis. Am J Dermatopathol 1981;3:381–2. Cross Ref link Pubmed link
• 221  Sanchez N, Ackerman AB. Subcorneal pustular dermatosis: a variant of pustular psoriasis. Acta Derm Venereol Suppl (Stockh) 1979;59(85):147–51. Pubmed link
• 222  Sanchez NP, Perry HO, Muller SA. On the relationship between subcorneal pustular dermatosis and pustular psoriasis. Am J Dermatopathol 1981;3(4):385–6. Cross Ref link Pubmed link
• 223  Sanchez NP, Perry HO, Muller SA, Winkelmann RK. Subcorneal pustular dermatosis and pustular psoriasis. A clinicopathologic correlation. Arch Dermatol 1983;119:715–21. Cross Ref link Pubmed link
• 224  Atukorala DN, Joshi RK, Abanmi A, Jeha MT. Subcorneal pustular dermatosis and IgA myeloma. Dermatology 1993;187(2):124–6. Cross Ref link Pubmed link
• 225  Cheng S, Edmonds E, Ben‐Gashir M, Yu RC. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol 2008;33:229–33. Cross Ref link Pubmed link
• 226  Marliere V, Beylot‐Barry M, Beylot C, Doutre M. Successful treatment of subcorneal pustular dermatosis (Sneddon–Wilkinson disease) by acitretin: report of a case. Dermatology 1999;199(2):153–5. Cross Ref link Pubmed link
• 227  Kawaguchi M, Mitsuhashi Y, Kondo S. A case of subcorneal pustular dermatosis treated with tacalcitol (1alpha,24‐dihydroxyvitamin D3). J Dermatol 2000;27(10):669–72. Cross Ref link Pubmed link
• 228  Orton DI, George SA. Subcorneal pustular dermatosis responsive to narrowband (TL‐01) UVB phototherapy. Br J Dermatol 1997;137:149–50. Cross Ref link Pubmed link
• 229  Bauwens M, De CA, Roseeuw D. Subcorneal pustular dermatosis treated with PUVA therapy. A case report and review of the literature. Dermatology 1999;198:203–5. Cross Ref link Pubmed link
• 230  Khachemoune A, Blyumin ML. Sneddon‐Wilkinson disease resistant to dapsone and colchicine successfully controlled with PUVA. Dermatol Online J 2003;9(5):24. Pubmed link
• 231  Lubach D, Edmuller M, Rahm‐Hoffmann AL. [Combined retinoid and UV‐phototherapy in pustulosis subcornealis (Sneddon‐Wilkinson).] Hautarzt 1980;31(10):545–7. Pubmed link
• 232  Zachariae CO, Rossen K, Weismann K. An unusual severe case of subcorneal pustular dermatosis treated with cyclosporine and prednisolone. Acta Derm Venereol 2000;80(5):386–7. Pubmed link
• 233  Verma KK, Pasricha JS. Ketoconazole as a therapeutic modality in subcorneal pustular dermatosis. Acta Derm Venereol 1997;77(5):407–8. Pubmed link
• 234  de Encarnacao Roque DF, Coelho JM, Ferreira AM, Fidalgo AI. Subcorneal pustular dermatosis treated successfully with adalimumab. Eur J Dermatol 2010;20(4):512–14. Pubmed link
• 235  Bedi MK. Successful treatment of long‐standing, recalcitrant subcorneal pustular dermatosis with etanercept. Skinmed 2007;6(5):245–7. Cross Ref link Pubmed link
• 236  Berk DR, Hurt MA, Mann C, Sheinbein D. Sneddon–Wilkinson disease treated with etanercept: report of two cases. Clin Exp Dermatol 2009;34(3):347–51. Cross Ref link Pubmed link
• 237  Howell SM, Bessinger GT, Altman CE, Belnap CM. Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil. J Am Acad Dermatol 2005;53(3):541–3. Cross Ref link Pubmed link
• 238  Bonifati C, Trento E, Cordiali FP, Muscardin L, Amantea A, Carducci M. Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon–Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids. Clin Exp Dermatol 2005;30(6):662–5. Cross Ref link Pubmed link
• 239  Voigtlander C, Luftl M, Schuler G, Hertl M. Infliximab (anti‐tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon‐Wilkinson disease). Arch Dermatol 2001;137:1571–4. Cross Ref link Pubmed link

Other neutrophilic dermatoses and variants

• 240  Femiano F, Lanza A, Buonaiuto C, Perillo L, Dell'Ermo A, Cirillo N. Pyostomatitis vegetans: a review of the literature. Med Oral Patol Oral Cir Bucal 2009;14:E114–17. Pubmed link
• 241  Hegarty AM, Barrett AW, Scully C. Pyostomatitis vegetans. Clin Exp Dermatol 2004;29:1–7. Cross Ref link Pubmed link
• 242  Ahn BK, Kim SC. Pyodermatitis–pyostomatitis vegetans with circulating autoantibodies to bullous pemphigoid antigen 230. J Am Acad Dermatol 2004;50(5):785–8. Cross Ref link Pubmed link
• 243  Nigen S, Poulin Y, Rochette L, Levesque MH, Gagne E. Pyodermatitis–pyostomatitis vegetans: two cases and a review of the literature. J Cutan Med Surg 2003;7(3):250–5. Cross Ref link Pubmed link
• 244  Mehravaran M, Kemeny L, Husz S, Korom I, Kiss M, Dobozy A. Pyodermatitis–pyostomatitis vegetans. Br J Dermatol 1997;137(2):266–9. Cross Ref link Pubmed link
• 245  Gonzalez‐Moles MA, Gil‐Montoya JA, Ruiz‐Avila I, Esteban F, Bascones‐Martinez A. Pyostomatitis vegetans: dramatic clinical response to clobetasol propionate treatment in aqueous solution. J Eur Acad Dermatol Venereol 2008;22(2):252–3. Pubmed link
• 246  Werchniak AE, Storm CA, Plunkett RW, Beutner EH, Dinulos JG. Treatment of pyostomatitis vegetans with topical tacrolimus. J Am Acad Dermatol 2005;52(4):722–3. Cross Ref link Pubmed link
• 247  Ficarra G, Cicchi P, Amorosi A, Piluso S. Oral Crohn's disease and pyostomatitis vegetans. An unusual association. Oral Surg Oral Med Oral Pathol 1993;75(2):220–4. Cross Ref link Pubmed link
• 248  Hegarty AM, Barrett AW, Scully C. Pyostomatitis vegetans. Clin Exp Dermatol 2004;29(1):1–7. Cross Ref link Pubmed link
• 249  Brinkmeier T, Frosch PJ. Pyodermatitis–pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low‐dose prednisolone. Acta Derm Venereol 2001;81:134–6. Cross Ref link Pubmed link
• 250  Mijandrusic‐Sincic B, Licul V, Gorup L, Brncic N, Glazar I, Lucin K. Pyostomatitis vegetans associated with inflammatory bowel disease–report of two cases. Coll Antropol 2010;34 Suppl. 2:279–82.
• 251  Bens G, Laharie D, Beylot‐Barry M, et al. Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease. Br J Dermatol 2003;149(1):181–4. Cross Ref link Pubmed link
• 252  Mendez‐Flores S, Charli‐Joseph Y, Saeb‐Lima M, Orozco‐Topete R, Fernandez SM. Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis. Dermatology 2013;226:1–4. Cross Ref link
• 253  Marzano AV, Ramoni S, Caputo R. Amicrobial pustulosis of the folds. Report of 6 cases and a literature review. Dermatology 2008;216:305–11. Cross Ref link Pubmed link
• 254  Claeys A, Bessis D, Cheikhrouhou H, Pouaha J, Cuny JF, Truchetet F. Amicrobial pustulosis of the folds revealing asymptomatic autoimmune thyroiditis. Eur J Dermatol 2011;21(4):641–2. Pubmed link
• 255  Lopez‐Navarro N, Alcaide A, Gallego E, et al. Amicrobial pustulosis of the folds associated with Hashimoto's thyroiditis. Clin Exp Dermatol 2009;34(8):e561–3. Cross Ref link Pubmed link
• 256  Lee HY, Pelivani N, Beltraminelli H, Hegyi I, Yawalkar N, Borradori L. Amicrobial pustulosis‐like rash in a patient with Crohn's disease under anti‐TNF‐alpha blocker. Dermatology 2011;222(4):304–10. Cross Ref link Pubmed link
• 257  Lim YL, Ng SK, Lian TY. Amicrobial pustulosis associated with autoimmune disease in a patient with Sjogren syndrome and IgA nephropathy. Clin Exp Dermatol 2012;37(4):374–8. Cross Ref link Pubmed link
• 258  Natsuga K, Sawamura D, Homma E, et al. Amicrobial pustulosis associated with IgA nephropathy and Sjogren's syndrome. J Am Acad Dermatol 2007;57(3):523–6. Cross Ref link Pubmed link
• 259  Amazan E, Ezzedine K, Mossalayi MD, Taieb A, Boniface K, Seneschal J. Expression of interleukin‐1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra. J Am Acad Dermatol 2014;71:e53–6. Cross Ref link Pubmed link
• 260  Lagrange S, Chosidow O, Piette JC, Wechsler B, Godeau P, Frances C. A peculiar form of amicrobial pustulosis of the folds associated with systemic lupus erythematosus and other auto‐immune diseases. Lupus 1997;6:514–20. Cross Ref link Pubmed link
• 261  Gambichler T, Boms S, Hochdorfer B, Altmeyer P, Kreuter A. Immunohistology of amicrobial pustulosis of the folds. Clin Exp Dermatol 2007;32(2):155–8. Cross Ref link Pubmed link
• 262  Boms S, Gambichler T. Review of literature on amicrobial pustulosis of the folds associated with autoimmune disorders. Am J Clin Dermatol 2006;7(6):369–74. Cross Ref link Pubmed link
• 263  Marzano AV, Menicanti C, Crosti C, Trevisan V. Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 2013;148:185–96. Pubmed link
• 264  Andre M, Aumaitre O, Papo T, et al. Disseminated aseptic abscesses associated with Crohn's disease: a new entity? Dig Dis Sci 1998;43(2):420–8. Cross Ref link Pubmed link
• 265  Wallach D, Vignon‐Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 2006;55:1066–71. Cross Ref link Pubmed link
• 266  Maeshima K, Ishii K, Inoue M, Himeno K, Seike M. Behcet's disease complicated by multiple aseptic abscesses of the liver and spleen. World J Gastroenterol 2013;19(20):3165–8. Cross Ref link Pubmed link
• 267  Andre MF, Aumaitre O, Grateau G, et al. Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients. Dig Dis Sci 2010;55:1681–8. Cross Ref link Pubmed link
• 268  Ito T, Sato N, Yamazaki H, Koike T, Emura I, Saeki T. A case of aseptic abscesses syndrome treated with corticosteroids and TNF‐alpha blockade. Mod Rheumatol 2013;23(1):195–9. Cross Ref link Pubmed link